Abstract
Background
A number of meta-analyses have demonstrated the effectiveness of bariatric surgery in improving morbid obesity and its associated co-morbidities. The aim of the study was to evaluate at long term a cohort of obese patients with type 2 diabetes (T2DM) submitted to laparoscopic sleeve gastrectomy (LSG) analyzing the incidence of weight regain (WR) and the impact of the WR on T2DM evolution.
Methods
Seventy-eight morbid obese patients (54 females) with T2DM, aged 49.6 ± 8.7 years, weight 121.1 ± 24.4 kg, BMI 44.1 ± 7.2 kg/m2, underwent primary LSG. The trend over time of T2DM after LSG was analyzed in the different groups, subdivided on the basis of the absence or presence of WR and of its different degrees: no regain (NR), mild regain (MR), and severe regain (SR) groups.
Results
In the NR group, 54% show complete remission, 46% persistence, and no case of diabetes relapse; in the MR group, 59% show complete remission, 36% persistence, and 5% relapse; in the SR group, 61% show complete remission, 22% persistence, and 17% relapse. A statistically significant difference concerns the preoperative values of fasting glucose, glycosylated hemoglobin, and duration of diabetes, major in the group with diabetes relapse (respectively, p = 0.002, p = 0.001, and p < 0.0001).
Conclusions
The results of this study showed no significant difference regarding the trend of diabetes remission comparing the “no regain,” “mild regain,” and “severe regain” groups and confirmed the importance of the duration of the illness and an early intervention towards surgical therapy.
Similar content being viewed by others
References
Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377(9765):557–67.
Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083–96.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–34. Erratum in JAMA. 2005; 293:1728
Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.
Pope GD, Finlayson SR, Kemp JA, et al. Life expectancy benefits of gastric bypass surgery. SurgInnov. 2006;13:265–73.
Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.
Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, et al. Delegates of the 2nd Diabetes Surgery Summit. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by International Diabetes Organizations.SurgObesRelat Dis 2016;12(6):1144–1162. doi: https://doi.org/10.1016/j.soard.2016.05.018
Sjostrom CD, Lissner L, Wedel H, et al. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS intervention study. Obes Res. 1999;7:477–84.
Sugerman HJ. Bariatric surgery for severe obesity. J AssocAcad Minor Phys. 2001;12:129–36.
Daniëlle S. Bonouvrie, Martine Uittenbogaart, Arijan A.P.M. Luijten, François M. H. van Dielen et al. Lack of standard definitions of primary and secondary (non)responders after primary gastric bypass and gastric sleeve: a systematic review. Obesity Surgery 2018 https://doi.org/10.1007/s11695-018-3610-4
Gracia JA, Martínez M, Elia M, et al. Obesity results surgery depends on technique performed: long term outcome. Obes Surg. 2009;19:432–8.
Sjöström L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. NEng J Med. 2004;351:2683–93.
Bohdjialian A, Langer FB, Shakeri-Leidenmuhler S, et al. Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg. 2010;20(5):535–40.
Freire RH, Borges MC, Alvarez-Leite JI, et al. Food quality, physical activity, and nutritional follow up as a determinant of weight regain after Roux-en-Y gastric bypass. Nutrition. 2012;28(1):53–8.
Yimcharoen P, Heneghan HM, Singh M, et al. Endoscopic findings and outcomes of revisional procedures for patients with weight recidivism after gastric bypass. SurgEndosc. 2011;25(10):3345–52.
Brethauer SA, Kim J, el Chaar M, et al. Standardized outcomes reporting in metabolic and bariatric surgery. SurgObesRelat Dis. 2015;11(3):489–506.
GuidelinesSID(Società Italiana Dibetologia) 2018
De Angelis F, Abdelgawad M, Rizzello M, Mattia C, Silecchia G. Perioperative hemorrhagic complications after laparoscopic sleeve gastrectomy: four-year experience of a bariatric center of excellence.SurgEndosc. 2017 Sep;31(9):3547–3551. https://doi.org/10.1007/s00464-016-5383-y.
Ruscio S, Abdelgawad M, Badiali D, et al. Simple versus reinforced cruroplasty in patients submitted to concomitant laparoscopic sleeve gastrectomy: prospective evaluation in a bariatric center of excellence. SurgEndosc. 2015;30(6):2374–238.
Guidelines ADA (American Diabetes Association) 2018
Obesity management for the treatment of type 2 diabetes 2018, ADA Diabetes Care 2018 Jan; 41 (Supplement 1): S65-S72
Guidelines, ASMBS (American Society for Metabolic and Bariatric Surgery), 2018
Reinhold RB. Critical analysis of long term weight loss following gastric bypass. SurgGynecol Obstet. 1982;155:385–94.
Lechner GW, Elliott DW. Comparison of weight loss after gastric exclusion and partitioning. Arch Surg. 1983;118(6):685–92.
Biron S, Hould FS, Lebel S, et al. Twenty years of biliopancreatic diversion: what is the goal of the surgery? Obes Surg. 2004;14:160.
Christou NV, Look D, Maclean LD. Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years. Ann Surg. 2006;244(5):734–40.
Brethauer SA, Aminian A, Romero-Talamás H, et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. AnnSurg. 2013;258:628–37.
Schauer PR et al. Bariatric surgery versus intensive medical therapy for diabetes- 5 year outcomes. N Engl J Med. 2017;376(7):641–51. https://doi.org/10.1056/NEJMoa160086.
Aminian A, Brethauer SA, Andalib A, et al. Can sleeve gastrectomy ‘cure’ diabetes? Long- term metabolic effects of sleeve gastrectomy in patients with type 2 diabetes. AnnSurg. 2016;264(4):674–81.
Capoccia D, Coccia F, Guarisco G, et al. Long-term metabolic effects of laparoscopic sleeve gastrectomy. F ObesSurg. 2018;28(8):2289–96. https://doi.org/10.1007/s11695-018-3153-8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000.
Informed Consent
Informed consent was obtained from all patients for being included in the study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Capoccia, D., Guida, A., Coccia, F. et al. Weight Regain and Diabetes Evolution After Sleeve Gastrectomy: a Cohort Study with over 5 Years of Follow-Up. OBES SURG 30, 1046–1051 (2020). https://doi.org/10.1007/s11695-019-04350-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-019-04350-0